Experimental Biology 2006 meets in San Francisco April 1-5

November 14, 2005

What: More than 12,000 biological and biomedical scientists will gather for Experimental Biology 2006 April 1-5, 2006. This annual meeting, now in its 15th year, brings together scientists from dozens of disciplines, from laboratory to translational to clinical research, from throughout the United States and the world. The theme of Experimental Biology 2006 is "Advancing the Biomedical Frontier." Thousands of lectures, symposia, research presentations, and exhibits present the newest scientific concepts and research findings shaping current and future clinical advances.

When: Saturday, April 1 through Wednesday, April 5.

Where: Moscone Convention Center, San Francisco, California.

Who: Sponsoring societies of Experimental Biology 2006 are: American Association of Anatomists; The American Physiological Society; American Society for Biochemistry and Molecular Biology (this year celebrating its 100th anniversary as the scientific organization most specifically focused on the chemistry of life); American Society for Investigative Pathology; American Society for Nutrition, Inc.; and American Society for Pharmacology and Experimental Therapeutics. Experimental Biology includes the annual meetings of these societies. Fourteen U.S. and international guest societies further broaden the scope of the meeting.

Why: Throughout the week, scientists - and reporters covering the meeting - choose among scientific presentations listed in telephone book-sized programs, searchable CD's, and the "fast-breaking" announcements made during the meeting itself. What makes the meeting unique is the ease with which scientists can move outside the boundaries of their own specialty. EB 2006 allows scientists to share information with colleagues who are tackling similar medical problems and other biomedical research areas from the viewpoint and using the tools of many different disciplines.

How: Experimental Biology 2006 is open to media across the globe representing print, electronic, online, general interest, trade and medical publishing companies. To register as press, email Sarah Goodwin at ebpress@bellsouth.net. Registrants will receive an extensive press kit, with more than 30 press releases. A pressroom will be available at the meeting, with daily media briefings by scientists presenting at the meeting. The American Physiological Society will operate an adjacent pressroom to facilitate access to its complementary program. For further information, contact Mayer Resnick at mresnick@the-aps.org.

Federation of American Societies for Experimental Biology

Related Clinical Research Articles from Brightsurf:

Day after COVID-19: Time to rethink oncology clinical research
This Viewpoint discusses how the COVID-19 pandemic may reshape clinical practice and clinical research as new technologies are incorporated and old practices are revisited and revamped.

Pregnant and lactating women with COVID-19: Scant clinical research
Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions.

Serum irisin: Pathogenesis and clinical research in cardiovascular diseases
In a new publication from Cardiovascular Innovations and Applications; Lutfu Askin, Kader Eliz Uzel, Okan Tanriverdi and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider serum irisin pathogenesis and clinical research in cardiovascular diseases.

People fearful of taking part in vital clinical research
A review, led by researchers at the University of York and Hull York Medical School, has found that fear about testing new treatments and possible side effects was the most common reason given by patients for not wanting to participate.

Clinical research improves health of UK economy and NHS
The value of clinical research to the NHS, the UK economy and jobs market has been evaluated in a new report, which provides an assessment of the economic impact of the National Institute for Health Research Clinical Research Network's (NIHR CRN) activities to support clinical research in England.

Research discovery leads to new clinical trial for myelofibrosis patients
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

New research: Financial disclosure lacking in publication of clinical trials
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows.

How to ethically conduct clinical research during public health emergencies
Carnegie Mellon University's Alex John London, a prominent bioethicist, has co-authored a viewpoint article in PLOS: Neglected Tropical Diseases on the ethics of clinical research during public health emergencies, like Ebola outbreaks.

Early results from clinical trials not all they're cracked up to be, shows new research
When people are suffering from a chronic medical condition, they may place their hope on treatments in clinical trials that show early positive results.

Collection provides tools to improve clinical research in Africa and Asia
Quality assurance of clinical research is critical to ensure meaningful results in compliance with universal ethical standards.

Read More: Clinical Research News and Clinical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.